EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae

Mariana Carvalho Sturaro, Gleyce Hellen de Almeida de Souza, Nathalia da Silva Damaceno, Osmar Nascimento Silva, Thiago Mendonça de Aquino, Nathalia Monteiro Lins Freire, Marcone Gomes Dos Santos Alcântara, Kadja Luana Chagas Monteiro, Aline Andrade Martins, Luana Rossato iD, Thiago Leite Fraga, Sibele Borsuk und 2 weitere

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkae382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Mariana Carvalho Sturaro und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Research in Health Science, Federal University of Grande Dourados, Dourados, Brazil. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Microbial Sensitivity Tests, Anti-Bacterial Agents, Polymyxin B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Coordination for the Improvement of Higher Education Personnel, Federal University of Grande Dourados.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the synergistic effect of a ceftibuten and polymyxin B combination and to determine its capacity to overcome polymyxin B resistance in polymyxin/carbapenem-resistant (PC-R) Klebsiella pneumoniae.

Methods

To investigate the combination’s antibacterial efficacy, antimicrobial susceptibility tests using broth microdilution methods, chequerboard assays and time–kill testing were performed. Antibiofilm activity was also assessed. The treatment’s effect on the bacterial cell membrane was examined by quantifying intracellular protein leakage and conducting scanning electron microscopy. Haemocompatibility tests were conducted to evaluate toxicity. Additionally, an infection model was established using Swiss mice to assess in vivo antimicrobial activity.

Results

The ceftibuten/polymyxin B combination demonstrated synergistic effects against several PC-R strains of K. pneumoniae, as determined by the FIC index (FICI) values, which ranged from 0.15 to 0.37. This combination was efficacious, exhibiting bactericidal activity at twice the MIC. Ceftibuten/polymyxin B also demonstrated antibiofilm activity. Additionally, ceftibuten/polymyxin B neither damaged the bacterial membrane nor exhibited haemolytic activity. Based on these findings, the in vivo therapeutic potential was investigated and it was found that ceftibuten/polymyxin B significantly decreased the bacterial load in the peritoneal lavage fluid of mice, revealing its effectiveness in treating infections caused by PC-R K. pneumoniae.

Conclusions

The ceftibuten/polymyxin B combination exhibited synergistic effects in vitro and in vivo, and thus might be a promising therapeutic alternative for treating PC-R K. pneumoniae infections. As the combination was efficacious in preclinical models, researchers may further investigate its potential in clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial AgentsPolymyxin BKlebsiella InfectionsDrug SynergismDisease Models, AnimalAnimalsMiceBiofilmsCephalosporinsCarbapenem-Resistant EnterobacteriaceaeCarbapenemsMicrobial Viability

Substanzen

Anti-Bacterial AgentsPolymyxin BCephalosporinsCarbapenems

Autor:innen und Institutionen

  • Laboratory of Research in Health Science, Federal University of Grande Dourados, Dourados, Brazil.
  • Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anápolis, Brazil.
  • Laboratory of Synthesis and Research in Medicinal Chemistry, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, Brazil.
  • University Center of Grande Dourados, Unigran, Dourados, Brazil.
  • Technology Development Center, Federal University of Pelotas, Pelotas, Brazil.

ORCID-Profile: Luana Rossato, Simone Simionatto

Förderung

  • National Council for Scientific and Technological Development
  • Coordination for the Improvement of Higher Education Personnel
  • Federal University of Grande Dourados
  • FUNDECT
  • CNPq
  • CAPES

Zitieren

APA

Sturaro, M. C., de Souza, G. H. A., Damaceno, N. D. S., Silva, O. N., de Aquino, T. M., Freire, N. M. L., Alcântara, M. G. D. S., Monteiro, K. L. C., Martins, A. A., Rossato, L., Fraga, T. L., Borsuk, S., Dellagostin, O. A., & Simionatto, S. (2025). Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae382

Vancouver

Sturaro MC, de Souza GHA, Damaceno NDS, Silva ON, de Aquino TM, Freire NML, et al. Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae382

BibTeX
@article{Sturaro2025,
  author = {Sturaro, Mariana Carvalho and de Souza, Gleyce Hellen de Almeida and Damaceno, Nathalia da Silva and Silva, Osmar Nascimento and de Aquino, Thiago Mendonça and Freire, Nathalia Monteiro Lins and Alcântara, Marcone Gomes Dos Santos and Monteiro, Kadja Luana Chagas and Martins, Aline Andrade and Rossato, Luana and Fraga, Thiago Leite and Borsuk, Sibele and Dellagostin, Odir Antônio and Simionatto, Simone},
  title = {Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkae382}
}
Kostenlos starten →